Target intelligence / Profile preview

Immunoglobulin lambda constant 5 (pseudogene) (IGLC5)

Target
IGLC5
Molecular classification
Other (pseudogene, immunoglobulin superfamily domain containing)
01

Overview

Immunoglobulin lambda constant 5 (IGLC5) is a human gene classified as a **pseudogene**, meaning it does not encode a functional protein[2][7][10]. It is part of the immunoglobulin lambda locus, where several functional and non-functional immunoglobulin constant region genes are arranged in tandem on human chromosome 22[4]. Unlike other immunoglobulin genes, IGLC5 is non-functional and not involved in immunoglobulin expression, immune response, or drug targeting. There is no evidence for its use as a therapeutic target, drug interaction, or disease biomarker[2][7][10]. **Key notes:** - IGLC5 is *not* a druggable target or a functional entity. - It is a noncoding pseudogene with no known biological, pathological, or pharmacological role in humans[2][4][7][10]. - Molecular and clinical information is lacking because of its non-functional (pseudogene) status. If you're seeking information on a functional immunoglobulin lambda constant gene, refer instead to IGLC1, IGLC2, or IGLC3.

Other names
IGLCimmunoglobulin lambda constant region 5 (pseudogene)IGLC5

Beyond the preview

Go deeper on Immunoglobulin lambda constant 5 (pseudogene) (IGLC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda constant 5 (pseudogene) (IGLC5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call